title: Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).
abstract: This European workshop identified a number of lessons learnt in the field of vaccine licensure, prioritization of target groups, communication on pandemic vaccines, implementation of vaccination and safety monitoring. The mild severity of the pandemic A(H1N1) 2009 influenza virus influenced the perception of pandemic vaccines, as previous pandemic preparedness had anticipated a more virulent virus. This vaccination experience provides an important opportunity for research on the long-term immunogenicity and safety of pandemic vaccines in pregnant women and children, as well as on the long-term safety of adjuvants. Preparedness for future pandemics could involve improved decision-making on target groups and increased communication on vaccine safety.
authors.affiliation: Health Care Knowledge Centre, Brussels, Belgium.
authors.forename: Germaine
authors.initials: G
authors.lastname: Hanquet
authors.forename: Pierre
authors.initials: P
authors.lastname: Van Damme
authors.forename: Daniel
authors.initials: D
authors.lastname: Brasseur
authors.forename: Xavier
authors.initials: X
authors.lastname: De Cuyper
authors.forename: Simon
authors.initials: S
authors.lastname: Gregor
authors.forename: Martin
authors.initials: M
authors.lastname: Holmberg
authors.forename: Rebecca
authors.initials: R
authors.lastname: Martin
authors.forename: Zsuzsanna
authors.initials: Z
authors.lastname: Molnár
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Pompa
authors.forename: René
authors.initials: R
authors.lastname: Snacken
authors.forename: Marianne
authors.initials: M
authors.lastname: van der Sande
authors.forename: Marc
authors.initials: M
authors.lastname: Van Ranst
authors.forename: Angela
authors.initials: A
authors.lastname: Wirtz
authors.forename: Pieter
authors.initials: P
authors.lastname: Neels
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D007251:Influenza, Human / Q000453:epidemiology* / Q000517:prevention & control* / Q000821:virology; D058873:Pandemics / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D014611:Vaccination / Q000379:methods*; D055815:Young Adult
chemical_list: D000276:Adjuvants, Immunologic; D007252:Influenza Vaccines